INTRODUCTION: Because of its lack of clinical signs, the detection of hepatitis C virus (HCV) infection in the Netherlands remains suboptimal. Therefore, the Dutch Health Council proposed an HCV campaign aimed to inform the general public and motivate people at risk to seek medical advice. Because knowledge and awareness of HCV infection is low among primary care workers, the implementation of a support programme for primary care complementary to a HCV campaign seems appropriate. OBJECTIVE: To evaluate the added value of a support programme for primary care complementary to a public HCV campaign. METHODS: We performed a non-randomized controlled intervention study. In two similar regions, a public HCV campaign was organized. In the intervention region, an additional support for primary care was provided by means of brochures, short courses and informative visits. RESULTS: In the intervention region, the proportional increase in anti-HCV tests was 3.02 (57-172 tests). In the control region, this increase was 1.36 (86-118 tests). In the intervention region, the increase in positive anti-HCV tests was 1.7% (95% confidence interval (CI): -0.2% to -3.7%). In the control region, this number decreased by 0.9% (95% CI: -4.1% to 2.3%). CONCLUSIONS: The addition of primary care practice support leads to considerable improvements in medical consciousness regarding HCV infection in primary care. Even though the positive effect on case finding cannot be indisputably demonstrated due to low prevalence, our results indicate such a positive effect. Therefore, future campaigns aimed at hepatitis C should invariably implement additional support for primary care to improve diagnostic uptake and optimize case finding.
INTRODUCTION: Because of its lack of clinical signs, the detection of hepatitis C virus (HCV) infection in the Netherlands remains suboptimal. Therefore, the Dutch Health Council proposed an HCV campaign aimed to inform the general public and motivate people at risk to seek medical advice. Because knowledge and awareness of HCV infection is low among primary care workers, the implementation of a support programme for primary care complementary to a HCV campaign seems appropriate. OBJECTIVE: To evaluate the added value of a support programme for primary care complementary to a public HCV campaign. METHODS: We performed a non-randomized controlled intervention study. In two similar regions, a public HCV campaign was organized. In the intervention region, an additional support for primary care was provided by means of brochures, short courses and informative visits. RESULTS: In the intervention region, the proportional increase in anti-HCV tests was 3.02 (57-172 tests). In the control region, this increase was 1.36 (86-118 tests). In the intervention region, the increase in positive anti-HCV tests was 1.7% (95% confidence interval (CI): -0.2% to -3.7%). In the control region, this number decreased by 0.9% (95% CI: -4.1% to 2.3%). CONCLUSIONS: The addition of primary care practice support leads to considerable improvements in medical consciousness regarding HCV infection in primary care. Even though the positive effect on case finding cannot be indisputably demonstrated due to low prevalence, our results indicate such a positive effect. Therefore, future campaigns aimed at hepatitis C should invariably implement additional support for primary care to improve diagnostic uptake and optimize case finding.
Authors: Angelique P A Vermeiren; Nicole H T M Dukers-Muijrers; Inge H M van Loo; Frans Stals; Dirk W van Dam; Ton Ambergen; Christian J P A Hoebe Journal: PLoS One Date: 2012-12-07 Impact factor: 3.240
Authors: Freke R Zuure; Anouk T Urbanus; Miranda W Langendam; Charles W Helsper; Charlotte H S B van den Berg; Udi Davidovich; Maria Prins Journal: BMC Public Health Date: 2014-01-22 Impact factor: 3.295
Authors: Esther Jane Aspinall; Joseph Samuel Doyle; Stephen Corson; Margaret Elena Hellard; David Hunt; David Goldberg; Tim Nguyen; Yngve Falck-Ytter; Rebecca Lynn Morgan; Bryce Smith; Mark Stoove; Stefan Zbyszko Wiktor; Sharon Hutchinson Journal: Eur J Epidemiol Date: 2014-11-11 Impact factor: 8.082
Authors: Carlos Roncero; Pablo Ryan; Richard Littlewood; Juan Macías; Juan Ruiz; Pedro Seijo; Raúl Felipe Palma-Álvarez; Pablo Vega Journal: Hepat Med Date: 2018-12-24
Authors: Lauren M K Mason; Irene K Veldhuijzen; Erika Duffell; Ayla van Ahee; Eveline M Bunge; Andrew J Amato-Gauci; Lara Tavoschi Journal: J Viral Hepat Date: 2019-08-16 Impact factor: 3.728
Authors: Eva van Oorschot; Özgür M Koc; Astrid Ml Oude Lashof; Inge Hm van Loo; Robin Ackens; Dirk Posthouwer; Ger H Koek Journal: J Virus Erad Date: 2022-06-20